Biomarin Pharmaceutical (NASDAQ:BMRN) is preparing to release its quarterly earnings on Tuesday, 2024-10-29. Here’s a brief overview of what investors should keep in mind before the announcement. Analysts expect Biomarin Pharmaceutical to report an earnings per share (EPS) of $0.52. The announcement from Biomarin Pharmaceutical is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter. It’s worth noting for new investors that guidance can be a key determinant of stock price movements. Earnings History SnapshotDuring the last quarter…